South Africa Abandons Oxford-AstraZeneca Covid-19 Vaccine In Favor Of Unapproved Johnson & Johnson Shot

The significant policy change is based on a small study that has not undergone peer review and did not evaluate the vaccine’s protection against severe disease, a key metric of success.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive